Alphagan

JPMorgan has maintained its Overweight rating on Allergan plc Ordinary Shares (NYSE: AGN), saying that the double-digit growth in the company's brands business is expected to continue throughout the year. Allergan's first quarter adjusted earnings of $3.04 a share topped the Street's estimate of $3...

Citi has maintained its Buy rating on Allergan plc Ordinary Shares (NYSE: AGN), saying the performance of the core brands "should not be overlooked." Allergan's first-quarter adjusted earnings of $3.04 per share topped the Street's estimate of $3.01. The company's adjusted top line grew 48.1...